Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature by A. Vaglio et al.
Concise Report
Peripheral inflammatory arthritis in patients with chronic
periaortitis: report of five cases and review of the literature
A. Vaglio1,*, A. Palmisano1,*, S. Ferretti2, F. Alberici1, I. Casazza1, C. Salvarani3 and C. Buzio1
Objectives. Chronic periaortitis (CP) is a rare disease with a potentially immune-mediated pathogenesis. The study aims to report the
frequency and the clinical characteristics of peripheral inflammatory arthritis in a cohort of CP patients, and to review the literature regarding
the association between arthritis and CP.
Methods. Forty-nine consecutive CP patients were seen at our department between 2000 and 2006; all of them underwent imaging
(abdominal computed tomography and magnetic resonance imaging) and laboratory examinations, also including erythrocyte sedimentation
rate, C-reactive protein and a panel of autoantibodies. The clinical history of the patients who developed peripheral inflammatory arthritis is
reported in detail. A PubMed/Medline search without any date limits was performed for English-language articles reporting the association
between CP and arthritis.
Results. Five of the 49 enrolled patients developed an inflammatory form of peripheral arthritis: three were diagnosed as having RA, one
palindromic rheumatism and one acute reactive arthritis. In all but one case, arthritis became clinically overt months to years after the onset of
CP, and its outcome was good, since almost all patients were asymptomatic at the end of follow-up. No patient suffered from ankylosing
spondylitis. In the literature review, 20 cases of CP-associated arthritis were found, mainly in the form of case reports: 14 of them were
spondyloarthropathies, whereas the remaining ones were RA, juvenile RA or undifferentiated arthritis.
Conclusions. Peripheral inflammatory arthritis, particularly RA or RA-like forms, may develop in CP patients. This overlap strengthens the
hypothesis of an autoimmune origin of CP.
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Introduction
Chronic periaortitis (CP) encompasses a group of rare diseases,
whose common denominator is a retroperitoneal periaortic fibro-
inflammatory tissue that frequently obstructs neighbouring
structures [1, 2]. Histology shows a collagen-rich background
and fibroblasts admixed with an inflammatory infiltrate consisting
of lymphocytes, plasma-cells, macrophages and eosinophils [1, 3].
CP includes non-aneurysmal [i.e. idiopathic retroperitoneal
fibrosis, (IRF)] and aneurysmal forms [i.e. inflammatory abdom-
inal aortic aneurysm (IAAA), perianeurysmal retroperitoneal
fibrosis] [2]. In some cases, it also involves the thoracic aorta,
leading to mediastinal fibrosis [4].
CP frequently arises in patients with atherosclerosis. Antibodies
to atherosclerotic plaque antigens (e.g. oxidized-low density
lipoproteins and ceroid) are detectable at higher titres in CP
patients than in controls, and adventitial lipid-laden macrophages
are found in CP aortic specimens [1, 5], which is why CP was
thought to be due to an inflammatory reaction to atherosclerosis.
However, it may also occur in patients without evidence of
atherosclerosis, and a number of findings such as the association
with HLA-DRB103, the presence of systemic symptoms and the
overlap with other autoimmune diseases, suggest that it may be
driven by a systemic autoimmune process [4, 6, 7].
Several reports have described the association between CP and
spondyloarthritis [8], whereas other types of arthritis appear to
be exceedingly rare [9]. Here we report five cases of CP-associated
peripheral inflammatory arthritis, selected from a cohort of 49
consecutive CP patients, and review the literature concerning the
association between CP and arthritis.
Patients and methods
Between 2000 and 2006, 49 consecutive CP patients were seen
at our department. CP was diagnosed by means of computed
tomography/magnetic resonance imaging (CT/MRI); histological
proof was available for 24 patients undergoing surgery for
ureterolysis or aneurysmectomy. Each patient underwent labo-
ratory tests including ESR, CRP, RF, ANA, anti-double stranded
DNA (dsDNA), anti-extractable nuclear antigen, ANCA and
anti-smooth muscle antibodies [7]. Anti-cyclic citrullinated peptide
(CCP)-antibodies only became available in our central laboratory
in May 2005. None of the patients had secondary forms of CP [4].
All patients initially received prednisone (1mg/kg/day for the
first month) and continued with tapering prednisone, tamoxifen
and/or immunosuppressants, according to ongoing protocols.
Remission of CP was defined as disappearance of symptoms,
normalization of ESR and CRP and resolution of obstructive
complications (e.g. hydronephrosis). The median follow-up was
36 months (range 12–117).
CP was associated with inflammatory arthritis in five patients,
whose main findings are summarized in Table 1. The ARA-revised
criteria [10] were used to diagnose RA.
Literature review
We searched PubMed/Medline without any date limits for
English-language articles reporting the association between CP
and arthritis and thus used the search terms ‘chronic periaortitis’,
‘retroperitoneal fibrosis’ or ‘inflammatory aortic aneurysm’,
matched with ‘arthritis’, ‘spondyloarthropathy’, ‘spondylitis’ or
‘arthropathy’. Table 2 shows the main findings of the cases
described in the literature [8, 9, 11–26].
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Case reports
Case 1
In October 2000, a 76-yr-old man was admitted to our department
because of fatigue and lumbar pain. He had undergone surgery
for IAAA, 1 yr earlier. Upon admission, serum creatinine was
1.9mg/dl, ESR 40 mm/I h, CRP 26mg/l (normal <5mg/l) and
ANA were positive (titre 1/80). CT demonstrated progressive
periaortic fibrosis encasing both ureters with resulting hydro-
nephrosis that required ureteral stents. Prednisone therapy led
to disease remission within 1 month and creatinine decreased to
1.5mg/dl. Prednisone was changed to tamoxifen; as CT showed
shrinkage of the periaortic tissue, the ureteral stents were removed
whereas tamoxifen was withdrawn after 8 months.
The patient returned to our hospital in July 2003, complaining
of a 2-month history of symmetric polyarthritis involving
the wrists, the metacarpal-phalangeal and the proximal inter-
phalangeal joints, the shoulders and knees. Morning stiffness
lasted at least 90min. Physical examination revealed swelling and
tenderness of the involved joints, and bilateral wrist flexor
tenosynovitis. X-rays showed periarticular soft tissue swelling
and juxta-articular osteoporosis of the proximal interphalangeal
joints and carpal bones. ESR was 106mm/I h, CRP 60mg/l, and
ANA titre 1/320; RF was 31 IU/ml (negative <15 IU/ml). RA was
diagnosed, and treatment with methylprednisolone (16mg/day)
and methotrexate (10mg/week) induced rapid clinical improve-
ment. Steroids were withdrawn 6 months later, and methotrexate
continued until July 2005. At the last visit (April 2006), the patient
was asymptomatic and no longer taking any drugs.
Case 2
In October 2000, a 54-yr-old woman was admitted to our
department because of hypogastric and lumbar pain. ESR was
15mm/I h and CRP 20mg/l; ANA (1/160) and anti-smooth
muscle antibodies (1/160) were also positive.
CT showed a 4 cm-wide IAAA. Prednisone therapy induced
disease remission, and was stopped after 9 months.
In September 2003, the patient reported episodes of arthritis
with morning stiffness of about 1 h duration, initially involving the
small joints of the hands and subsequently migrating to the elbows
and metatarsal-phalangeal joints. The duration of the attacks was
1–2 days, and their frequency fortnightly. ESR and CRP were
high, and RF positive (198 IU/ml). A radiogram of the involved
joints was normal. Palindromic rheumatism was diagnosed; the
patient continued taking NSAIDs during the attacks and no
progression to RA was observed during the following 2 yrs.
Case 3
In April 2001, a 58-yr-old man was admitted to our department
because of perineal pain and left-sided varicocele. In December
1995, he had received a diagnosis of IRF and had undergone
bilateral ureterolysis.
TABLE 2. Clinical findings of the cases reported in the English-language literature of chronic periaortitis associated with inflammatory arthritis
Reference
Sex, age
(yrs)a Type of CP
Type of
arthritis
Time
CP-arthritis
(yrs)b HLA-B27 RF
Arthritis
treatment CP treatment
Arthritis
outcome
CP
outcome
Reidbord and Hawk [11] M, 51 IRF SA 0 NA NA NA None Death Death
Hissong and Freimanis [12] M, 64 IRF SA 0 NA NA NA Ureterolysis Improved Improved
Wacksman et al. [13] F, 7 IRFþMF JRA NA NA NA Aspirin Steroids Stable Improved
Littlejohn and Keystone [14] M, 24 IRFþMF SA þ1 Pos. NA Steroids, AZA Steroids irradiation Remission Improved
Goldbach et al. [15] F, 28 IRFþMF SA 0.5 Neg. Neg. NSAIDs Steroids Arthralgia NA
Goldbach et al. [15] F, 34 MF SA 0 Neg. Neg. Salicylates Steroids NA Remission
Solomon and Maurer [16] M, 51 IRF SA 20 Pos. NA Indomethacin Ureterolysis Improved Improved
Wicks et al. [17] F, 72 IRF SA 0 Neg. NA Steroids Ureterolysis steroids Remission Remission
Reilly and Moran [18] M, 64 IRF SA 30 NA NA Irradiation Steroids Improved Improved
DeLa Iglesia et al. [19] F, 63 IRF SA 35 Neg. Neg. NA Ureterolysis steroids Improved Improved
Tsai et al. [9] F, 13 IRF JRA 10 Neg. Neg. Aspirin Steroids Improved NA
Boonen et al. [20] M, 42 IRFþMFc Unclassified NA Neg. NA Steroids D-PCM Steroids D-PCM Improved Improved
Leblanc et al. [8] M, 7 IRF SA 6 Neg. Neg. aspirin, steroids,
AZA, indomethacin
Ureterolysis steroids Arthralgia Remission
Wendling et al. [21] M, 66 IAAA SA 3 Neg. NA MTX NA NA Remission
Bezza et al. [22] M, 52 IRF SA 0 Pos. NA NSAIDs Steroids Remission Remission
Takagi et al. [23] F, 68 IAAA SA 0 Pos. Neg. NSAIDs Aneurysmectomy Remission Remission
Haug et al. [24] NA IAAA RA NA NA Pos. NA NA NA NA
Haug et al. [24] NA IAAA RA NA NA Neg. NA NA NA NA
Afeltra et al. [25] M, 63 IRF SA 13 Pos. Neg. Steroids MTX Steroids MTX
ureterolysis
Remission Remission
Lemke et al. [26] M, 61 IRFþ thoracic
periaortitis
RA NA NA NA NA NA Remission Remission
a At the time of onset of CP. bTime interval between the diagnoses of CP and arthritis; ‘þ’ and ‘’ indicate that CP, respectively, preceded or followed the onset of arthritis. cAssociated with SAPHO
syndrome. SA, spondyloarthritis; MF, mediastinal fibrosis; D-PCM, D-penicillamine; NA, not available.
TABLE 1. Main clinical and laboratory features of the five patients with CP-associated inflammatory arthritis
Patient
No.
Sex,
age (yrs)a
Type of
CP
ANA
titrea Type of arthritis
Time
CP-arthritis
(months)b RFc CP treatment CP outcome Arthritis treatment
Arthritis symptoms
at last visit
1 M, 76 IAAA 1/80 Rheumatoid arthritis þ45 Pos. Aneurysmectomy,
PDN, TXF
Remission PDNþMTX Absent
2 F, 54 IAAA 1/160 Palindromic rheumatism þ35 Pos. PDN Remission NSAIDs Absent
3 M, 52 IRF NA Reactive arthritis þ67 Neg. PDN, TXF Remission NSAIDsþ antibiotics Absent
4 F, 51 IRF 1/640 Rheumatoid arthritis 120 Pos. PDN Remission Salazopyrinþ NSAIDs Improved
5 F, 63 IRF 1/320 Rheumatoid arthritis þ22 Pos. PDN (ureterolysis
after relapse)
Relapse MPþ HCQ Improved
PDN, prednisone; TXF, tamoxifen; MP, methylprednisolone; NA, not available. aAt the time of diagnosis of CP. bTime interval between the diagnoses of CP and arthritis; ‘þ’ and ‘’, respectively
indicate that CP preceded or followed the onset of arthritis. cAssessed at onset of arthritis.
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Upon admission, ESR and CRP were high (48mm/I h and
41mg/l, respectively), autoantibodies were negative. Prednisone
therapy rapidly led to disease remission, and 1 month later it was
changed to tamoxifen. Two months later, the patient presented
with acute arthritis involving the left elbow, which was markedly
swollen and tender; he also reported self-limiting diarrhoea
3 weeks prior to the arthritis attack. CRP was again high and
RF negative. Synovial fluid and stool cultures were negative,
but serum antibodies to Salmonella were positive. Although
tamoxifen-induced arthritis was also considered, diagnosis of
reactive post-infectious arthritis seemed more likely. NSAIDs
and amoxicillin plus clavulanic acid induced symptom remission
within a few weeks and, 2 months later, no signs of joint inflam-
mation were observed.
Tamoxifen was withdrawn in February 2002. The follow-up
continued until May 2005, and no articular manifestations were
reported.
Case 4
In April 2001, a 51-yr-old woman was referred to our department
because of suspected IRF.
RA had been diagnosed based on symmetric polyarthritis
involving the metatarsal joints, the small joints of the hands and
knees, positive RF and radiographic evidence of bone erosions
adjacent to the metatarsal–phalangeal joints, 10 yrs earlier. Good
control of arthritis had been achieved with short methylpred-
nisolone courses.
On admission, she was taking no drugs and complained of
abdominal pain and fatigue. Abdominal sonography showed left-
sided hydronephrosis, and CT disclosed IRF enveloping the left
ureter. CRP levels were high (20mg/l), whereas ESR and serum
creatinine were normal; ANA were positive (1/640) and RF high
(55 IU/ml). The patient also complained of bilateral knee pain, but
physical examination and X-rays were unremarkable.
A ureteral stent led to the resolution of the hydronephrosis, and
treatment with prednisone induced IRF remission, which was also
demonstrated by CT. The ureteral stent was removed after
6 months of steroid therapy that was continued for another
3 months. Two months after steroid withdrawal, the patient
complained of metatarsal and knee pain; physical examination
disclosed bilateral knee swelling and stress pain of the metatarsal–
phalangeal joints. Treatment with salazopyrin and NSAIDs
promptly induced disappearance of arthritis symptoms. In April
2005, the patient spontaneously stopped salazopyrin and, during
the following months, reported subcontinuous hip pain.
Case 5
In February 2003, a 63-yr-old woman was admitted to our
department because of lumbar and abdominal pain. Serum
creatinine was 8.1mg/dl, ESR 100mm/I h and CRP 182mg/l
and ANA were positive (1/320). MRI disclosed IRF with bilateral
ureteral involvement, which required stent placement; creatinine
normalized (1.1mg/dl). Prednisone therapy was started and after 4
months MRI showed a shrinkage of the IRF, so the ureteral stents
were removed and the patient continued steroid tapering for
another 4 months. Steroid withdrawal, however, was followed by
enlargement of IRF and relapsing hydronephrosis. Surgical
ureterolysis was thus performed and another 8-month prednisone
course was administered.
Two months after treatment withdrawal, the patient reported
joint pain and swelling symmetrically involving the wrists, the
metacarpal–phalangeal and proximal interphalangeal joints.
Despite NSAID administration, the pain and swelling progressed
to involve both elbows, the left ankle, right knee and shoulder.
Laboratory tests demonstrated high ESR (60mm/I h), CRP
(66mg/l) and RF levels (81.8 IU/ml) and positive anti-CCP
antibodies (50 IU/ml, negative <25 IU/ml). RA was diagnosed;
treatment with methylprednisolone (initial dose, 16mg/day) and
hydroxychloroquine (400mg/day) led to the disappearance of the
arthritis symptoms. Five months later, steroids were withdrawn,
but left ankle arthritis relapsed and low-dose methylprednisolone
was resumed. In December 2006, the patient was asymptomatic.
Discussion
We identified five of 49 consecutive CP patients who also had
peripheral inflammatory arthritis: three developed RA, one
palindromic rheumatism and one reactive arthritis. In all but
one case, the arthritis became clinically overt months to years after
CP, although the administration of steroids for CP may have
accounted for a delay in its onset. The clinical course of arthritis
was benign and quite atypical if compared with classical RA cases,
since most patients remained asymptomatic even after treatment
withdrawal.
These findings broaden the spectrum of diseases associated with
CP, and further support the view that autoimmune mechanisms
contribute to its pathogenesis [27] and that it may be a systemic
disorder. However, since RA has a prevalence of 1% in the
general population, it cannot be statistically excluded that its
overlap with CP (8% of our cases) is coincidental.
The review of the English-language literature provided 20
cases—mostly case reports—showing an association between CP
and arthritis. Fourteen of these patients had spondyloarthritis,
whereas other forms such as RA were extremely rare. Our findings
thus challenge the view that spondyloarthritis is the most common
arthritis occurring in CP patients; conversely, they show that RA
or other entities such as palindromic rheumatism (often con-
sidered a smouldering form of RA) are more frequent. Compared
with previous reports, our study has the advantage of having
screened quite a large population of CP patients for associations
with other immune-mediated diseases; in addition, our patients
had a long follow-up that allowed detection of overlapping
conditions such as arthritis.
Of the 14 reported cases of CP-associated spondyloarthritis,
five were HLA-B27-positive [14, 16, 18, 22, 23, 25], which led to
the hypothesis that HLA-B27 may be a genetic risk factor for CP
[8, 14]. However, in a recent study, we found that HLA-DRB103
but not HLA-B27 is associated with an increased susceptibility
to CP [6].
The overlap between CP and RA suggests that these two
diseases may follow common immune-mediated pathways. RA is
an archetypal example of autoimmune disease hallmarked by the
production of autoantibodies (e.g. RF, ANA and anti-CCP) [28].
Similarly, circulating autoantibodies (e.g. ANA, anti-smooth
muscle antibodies) have also been found in CP patients
[5–7, 24]. The presence of autoantibodies, the association with
HLA-DRB103 and the abundance of B cells in the retro-
peritoneal lesions also indicates that, like in RA, B cells play a
major role in CP.
Similarities between CP and RA are also found by examining
the composition and architectural organization of the inflamma-
tory infiltrate in the diseased sites. As in RA, the key players of the
inflammatory infiltrate in CP lesions are B- and T-cells, plasma
cells and macrophages [1, 4, 28]. The topographic distribution
of the inflammatory elements shows similar patterns in RA and
CP: mononuclear cells may be diffusely distributed within the CP
lesions (as in the ‘diffuse’ synovitis) or arranged in aggregates and
sometimes show germinal centre reactions, as observed in a subset
of RA patients [28–30].
Finally, both RA and CP have a restricted HLA repertoire,
although the disease-associated alleles are different (HLA-
DRB104 and HLA-DRB103, respectively) [6, 28].
In conclusion, different forms of peripheral inflammatory
arthritis, particularly RA, may occur in CP patients; this
reinforces the hypothesis of an autoimmune origin of CP and
suggests that the two diseases share common pathophysiological
mechanisms.
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Rheumatology key messages
 Inflammatory arthritis, particularly RA or RA-like forms, may be
part of the spectrum of CP.
 The association with RA supports the hypothesis that CP may
have an autoimmune origin.
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